About
Wayfinder at 53 Stations who participated in panel discussions on energy transition and advanced nuclear power at the 2026 portfolio summit.
Experience
- PermiraSenior Advisorcurrent2026 β presentLondon Area, United Kingdom & New York, NY
- UChicago MedicineBoard Trusteecurrent2025 β present
- AnswersNowBoard Membercurrent2022 β present
- VitestroAdvisorcurrent2024 β present
- Palvella TherapeuticsFounding Investorcurrent2016 β present
- Magee VenturesPrincipalcurrent2021 β presentChicago, Illinois, United States
- 53 StationsAdvisor2025 β 2026Chicago, IL
- BinaxityAdvisor2024 β 2025
- KinnosBoard Chair2022 β 2025New York, NY
- 3NT MedicalAdvisor2012 β 2025
- Flik TherapeuticsBoard Member2024 β 2025
- Kapor CapitalAdvisor2022 β 2024Oakland, California, United States
- Partum HealthAdvisor2021 β 2023Chicago, Illinois, United States
- BDAdvisor2021
- Velano Vascular, Inc.Chief Executive Officer & Co-founder2011 β 2021San Francisco, CA
- Crohn's & Colitis FoundationNational Trustee & Executive Committee Member2013 β 2020New York, New York, United States
- Vigilant Biosciences, Inc.Director, Board of Directors2011 β 2018
- MolecularHealthVice President, Sales and Marketing2011 β 2013New York, NY
- Harvard Alumni AssociationDirector & Committee Chair2003 β 2013Cambridge, MA
- Abbott VascularProduct & Commercial Marketing2007 β 2011San Francisco Bay Area and Brussels, Belgium
Education
- The Wharton SchoolMBA, Health Care Management2005 β 2007
- Harvard UniversityEd.M., Human Development & Leadership2002 β 2003
- University of PennsylvaniaBA, English/Psychology1995 β 1999
Skills & more
Business Development44Product Management17Marketing Strategy4Business Strategy9Commercialization6Competitive Analysis6Start-ups46Marketing4Management16Strategy32
From Phill's professional profile.
Same school
Also attended The Wharton School1,323
Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures
+ 1,317 more
Also attended Harvard University1,173
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,167 more
Also attended University of Pennsylvania607
Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution
+ 601 more
Shared employers
Also worked at AnswersNow2
Also worked at Vitestro1
Also worked at BD14
Matthew McCooeChief Executive Officer at Connecticut InnovationsIan ChiangPartner at Flare Capital PartnersPaola RetesVice President at LiveOak VenturesNatalie WisniewskiCompany Building Partner at Material ImpactSean SullivanT1D Moonshot Impact Board at StartUp HealthAvery SonnenbergPrincipal at Two Bear Capital
+ 8 more
Also worked at Abbott Vascular51
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalCharles BeyrouthyFounder & Managing Partner at Forma PrimeFederico RaneroVenture Partner at NazcaJennifer SmoterChief Communications & Governance Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures
+ 45 more




.jpeg)

























